Definitive Analysis
Financial Statements
Periods / Units
Fundamentals
Valuations
Miscellaneous
Analysis Mode
Full Access
See Pricing Start Trial
Multiples Valuation: Zoetis Inc.

Zoetis Inc. (0M3Q.L)

Industry: Medical - Pharmaceuticals Model: Peers Multiples Valuation

Valuation Snapshot

Winsorized Fair Value
Range (Low - High) $88.41 — $106.78
Selected (Average) $99.95
Upside to Live -20.06%
Full Range Fair Value
Range (Low - High) $90.49 — $121.47
Selected (Average) $107.52
Upside to Live -14.00%
Live Price $125.02

Industry Peers Data

TickerRankNameRev TTM (M) Trailing P/EForward P/ETrailing EV/EBITDAForward EV/EBITDATrailing EV/EBITForward EV/EBIT
WBA 1 Walgreens Boots Al 154,580 - - - - 179.24 -
ESRX 2 Express Scripts Ho 101,353 10.92 8.98 8.82 8.49 10.88 11.21
NOVC.DE 3 Novo Nordisk A/S 42,536 32.04 26.79 22.25 18.71 22.36 21.64
RAD 4 Rite Aid Corporati 23,475 - - - - - -
600998.SS 5 Jointown Pharmaceu 22,383 8.78 8.82 13.60 14.00 14.62 12.56
0SAN.L 6 Sandoz Group AG 20,756 76.13 76.13 21.22 21.22 11.56 14.46
0M3Q.L 7 Zoetis Inc. 9,397 24.45 22.27 15.53 14.33 16.81 16.27
3141.T 8 Welcia Holdings Co 8,445 29.12 30.75 9.73 9.69 17.16 13.95
RADL3.SA 9 Raia Drogasil S.A. 7,650 23.54 18.57 11.43 10.02 13.15 12.13
3391.T 10 Tsuruha Holdings I 7,260 19.33 19.32 7.37 7.21 7.65 9.44
FRAGUAB.MX 11 Corporativo Fragua 6,991 11.32 9.24 5.54 4.54 6.62 5.60
3088.T 12 MatsukiyoCocokara 6,970 21.26 17.77 9.94 8.23 13.16 10.64
3349.T 13 COSMOS Pharmaceuti 6,565 22.53 21.38 10.65 10.00 14.82 16.35
002758.SZ 14 ZJAMP Group Co., L 6,292 10.35 5.66 6.61 4.17 9.03 3.42
7649.T 15 Sugi Holdings Co., 6,195 16.35 14.53 9.65 8.70 11.97 12.41
0Y5E.L 16 Perrigo Company pl 5,028 - - 4.21 4.21 8.87 8.80

Implied Valuation Analysis

Line Item Trailing P/EForward P/ETrailing EV/EBITDAForward EV/EBITDATrailing EV/EBITForward EV/EBIT
Winsorized Median Multiple17.8416.159.658.4911.7711.21
Full Range Median Multiple20.2918.179.738.7012.5612.13
Industry Multiple23.4721.5010.859.9424.3611.74
Market Implied Multiple20.8919.0313.2012.1814.2913.83
Company (0M3Q.L) Multiple24.4522.2715.5314.3316.8116.27
(*) Net Income / EBITDA / Revenue2,6512,9104,0514,3923,7443,869
Winsorized Enterprise ValueN/AN/A39,08137,27644,06043,366
Full Range Median Enterprise ValueN/AN/A39,40038,19947,03346,908
(-) Net Debt-1,880-1,880-1,880-1,880-1,880-1,880
Winsorized Equity Value47,29446,99840,96139,15645,94045,246
Full Range Median Equity Value53,80052,87141,28040,07948,91348,788
(/) Shares Outstanding443443443443443443
Winsorized Fair Value$106.78$106.11$92.48$88.41$103.73$102.16
Full Range Median Fair Value$121.47$119.37$93.20$90.49$110.44$110.16
Current Price$125.02$125.02$125.02$125.02$125.02$125.02
Upside / Downside-14.59%-15.12%-26.03%-29.28%-17.03%-18.29%
Safety Margin30.0%30.0%30.0%30.0%30.0%30.0%
Buy Price$74.75$74.28$64.74$61.89$72.61$71.51
Buy / Don't BuyDon’t BuyDon’t BuyDon’t BuyDon’t BuyDon’t BuyDon’t Buy